"Abbott" TDM complex correction solution
Taiwan·Risk Class 2·MICROGENICS CORPORATION·Registered Nov 23, 2020 – Nov 23, 2025Expired- Analysis ID
- c390acbd004b6f42d727059d5dc2ec82
- Customs Code
- DHA05603415902
- Manufacturer
- MICROGENICS CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
- Intended Use
- Suitable for in vitro diagnostics, calibration of human serum or plasma amikacin, carbamazepine, digoxin, gentamicin, phenobarbital, phenytoin, theophylline, valproic ACID) and vancomycin analysis.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 Calibrated Products
- Import Information
- QMS/QSD;; 輸入
- Registration Date
- Nov 23, 2020
- Expiry Date
- Nov 23, 2025
Top companies providing products similar to ""Abbott" TDM complex correction solution"
Recently registered similar products
Access comprehensive regulatory information for "Abbott" TDM complex correction solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c390acbd004b6f42d727059d5dc2ec82 and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including B.R.A.H.M.S GmbH;; MICROGENICS CORPORATION, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.